Chemical inhibitors of ZNF132 operate through various pathways to achieve functional inhibition of this protein. PD 98059 acts by inhibiting MEK, a kinase within the MAPK/ERK pathway, which is crucial for the phosphorylation events that ZNF132 requires for its function. By halting MEK, PD 98059 indirectly prevents the phosphorylation and activation of ZNF132, impeding its role in gene expression regulation. LY294002 and Wortmannin are both inhibitors of PI3K, a pivotal kinase in the PI3K/Akt signaling pathway. By inhibiting PI3K, these compounds reduce Akt phosphorylation, thereby decreasing the downstream signaling that influences ZNF132's activity within the cell. SP600125 targets JNK, another kinase whose activity is necessary for ZNF132's function in its signaling pathways, and its inhibition results in decreased ZNF132 activity. U0126 and SB203580 are also kinase inhibitors that target MEK and p38 MAP kinase respectively, both of which are integral to the pathways ZNF132 is involved in. U0126 prevents ERK activation, while SB203580 directly inhibits p38 MAP kinase, both leading to a reduction in the signaling required for ZNF132 activity.
Additional compounds such as PP2, Y-27632, and GF109203X target other kinases and enzymes that indirectly regulate ZNF132. PP2 inhibits Src family kinases, disrupting upstream signaling necessary for ZNF132's function. Y-27632 is a ROCK inhibitor that affects cytoskeletal dynamics, which can influence ZNF132's DNA-binding capability and consequently its gene regulatory functions. GF109203X, a Protein kinase C inhibitor, disrupts critical signaling pathways that ZNF132 requires for its modulation. Rapamycin, an mTOR inhibitor, disrupts the mTOR signaling pathway, leading to the downregulation of several processes in which ZNF132 is implicated. Triptolide targets transcription factors and RNA polymerase II, which are essential for the transcriptional regulation activities of ZNF132, thereby indirectly inhibiting its function. Lastly, Apigenin inhibits CK2, an enzyme that can alter the phosphorylation state of proteins that interact with or regulate ZNF132, thus indirectly impeding ZNF132's functional activities within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which indirectly inhibits ZNF132 by preventing its necessary phosphorylation events within the MAPK/ERK pathway, a pathway ZNF132 operates within. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, reducing Akt phosphorylation and downstream signaling that would normally impact ZNF132 function within the PI3K/Akt signaling pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor that disrupts signal transduction pathways, indirectly inhibiting ZNF132 by impairing necessary upstream kinase activity for function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, which is involved in the signaling pathway of ZNF132, thereby inhibiting its downstream effects on gene expression and cellular responses. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor preventing ERK activation, thereby inhibiting downstream effects on ZNF132, which relies on this pathway for its functional activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, and by doing so, indirectly inhibits ZNF132 activity as JNK is part of the signaling pathways that ZNF132 is involved in. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor that can indirectly inhibit ZNF132 function by altering the cytoskeletal dynamics and potentially affecting its DNA-binding capability. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor, which can reduce the activity of downstream signaling pathways essential for ZNF132's role in cellular processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, which can indirectly inhibit ZNF132 function by disrupting the mTOR signaling pathway that ZNF132 is involved in. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Protein kinase C inhibitor, which can indirectly inhibit ZNF132 by disrupting signaling pathways necessary for its functional modulation. | ||||||